Korman, Neil, Kim Papp, Jerry Bagel, Peter Foley, Akimichi Morita, Subhashis Banerjee, Elizabeth Colston, Tao Wang, John Throup, and Diamant Thaci. “Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, Versus Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Onset of Action in the Phase 3 POETYK PSO-1 and POETYK PSO-2 Trials”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s39. Accessed May 17, 2022. https://www.jofskin.org/index.php/skin/article/view/1390.